Cite
MLA Citation
Elżbieta Iskierka-Jażdżewska et al.. “Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.” Leukemia & lymphoma, vol. 61, no. 3, 2020, pp. 699–706. http://access.bl.uk/ark:/81055/vdc_100101505554.0x000026